Role of Oxidized Phospholipids in Phenotypic Switching of Smooth Muscle Cells (SM

氧化磷脂在平滑肌细胞(SM)表型转换中的作用

基本信息

  • 批准号:
    7371716
  • 负责人:
  • 金额:
    $ 37.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-02-01 至 2013-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): There is clear evidence that phenotypic switching of the vascular smooth muscle cell (SMC) plays a critical role in development of atherosclerotic disease, and end stage clinical consequences such as plaque rupture/thrombosis. However, the mechanisms and factors that regulate SMC phenotypic switching in atherogenesis are poorly understood. In addition, although there is compelling evidence that oxidized phospholipids (oxPLs) play a critical role in activation of endothelial cells and monocytes/macrophages during atherogenesis, virtually nothing is known regarding the role of oxPLs in control of phenotypic switching of vascular SMC. The focus of this proposal is to test the hypothesis that oxidized 1-palmitoyl-2-arachidonoyl-sn- glycero-3-phosphorylcholine (OxPAPC) and its oxPL components POVPC and PGPC play a key role in regulating SMC phenotypic switching associated with experimental vascular injury/atherogenesis, and that the effects of these compounds are mediated at least in part through the G/C repressor/TCE binding protein KLF4 and ERK-dependent phosphorylation of ELK1. In support of this hypothesis, we found that oxPAPC, POVPC, and PGPC profoundly suppressed expression of all SMC differentiation marker genes tested to date including SM a-actin, SM myosin heavy chain (MHC), and myocardin in cultured SMC, as well as in carotid arteries in vivo. In contrast, oxPLs increased expression of KLF4, a gene we have previously shown can markedly suppress expression of the potent SMC selective SRF co-activator myocardin (and myocardin like factors), and induce histone modifications of SMC marker gene loci associated with chromatin condensation and transcriptional silencing. In addition, we present preliminary data showing that POVPC-induced suppression of SMC differentiation marker genes in cultured SMC and in vivo can be inhibited by siRNA-induced suppression of KLF4. Aim 1 will determine mechanisms by which oxPLs suppress expression of SMC differentiation marker genes such as SM a-actin, SM MHC, and SM22a and will include investigation of the role of inhibition of CArG-SRF-myocardin dependent transcription by KLF4 and phospho-ELK1. Aim 2 will determine the role and mechanisms by which oxPLs regulate SMC phenotypic switching in vivo in response to vascular injury and/or experimental atherosclerosis using a novel pluronic gel system developed in our labs in combination with unique SMC promoter-reporter transgenic mice, and conditional KLF4/ApoE knockout mice. Taken together, studies will provide novel insights regarding cellular and molecular mechanisms whereby oxPLs contribute to phenotypic switching of SMC in atherogenesis, and may lead to development of novel therapies for inhibiting atherosclerotic lesion formation, progression, and/or plaque rupture.
描述(由申请方提供):有明确证据表明,血管平滑肌细胞(SMC)的表型转换在动脉粥样硬化疾病的发展和终末期临床后果(如斑块破裂/血栓形成)中起关键作用。然而,在动脉粥样硬化形成中调节SMC表型转换的机制和因素知之甚少。此外,虽然有令人信服的证据表明,氧化磷脂(oxPL)在动脉粥样硬化形成过程中的内皮细胞和单核细胞/巨噬细胞的活化中发挥关键作用,几乎没有什么是已知的oxPL在控制血管SMC的表型转换的作用。本提案的重点是检验以下假设:氧化的1-棕榈酰-2-花生四烯酸酰-sn-甘油基-3-磷酸胆碱(OxPAPC)及其oxPL组分POVPC和PGPC在调节与实验性血管损伤/动脉粥样硬化相关的SMC表型转换中起关键作用,并且这些化合物的作用至少部分通过G/C阻遏物/TCE结合蛋白KLF 4和ERK介导。依赖于ELK 1的磷酸化。为了支持这一假设,我们发现oxPAPC、POVPC和PGPC深刻地抑制了迄今为止测试的所有SMC分化标志物基因的表达,包括在培养的SMC中以及在体内颈动脉中的SM α-肌动蛋白、SM肌球蛋白重链(MHC)和心肌蛋白。相比之下,oxPL增加KLF 4的表达,KLF 4是我们先前已经显示的基因,可以显著抑制有效的SMC选择性SRF共激活因子心肌素(和心肌素样因子)的表达,并诱导与染色质凝聚和转录沉默相关的SMC标记基因位点的组蛋白修饰。此外,我们目前的初步数据表明,POVPC诱导的抑制SMC分化标记基因在培养的SMC和体内可以抑制siRNA诱导的抑制KLF 4。目的1将确定oxPL抑制SMC分化标记基因如SM α-肌动蛋白、SM MHC和SM 22 a表达的机制,并将包括研究KLF 4和磷酸化-ELK 1抑制CArG-SRF-心肌蛋白依赖性转录的作用。目的2将确定oxPLs调节SMC表型转换的作用和机制,在体内血管损伤和/或实验性动脉粥样硬化使用一种新的pluronic凝胶系统在我们的实验室开发的独特的SMC启动子报告基因转基因小鼠,和条件KLF 4/ApoE基因敲除小鼠相结合。总之,研究将提供关于oxPL在动脉粥样硬化形成中促进SMC表型转换的细胞和分子机制的新见解,并可能导致开发用于抑制动脉粥样硬化病变形成、进展和/或斑块破裂的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gary K Owens其他文献

Gary K Owens的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gary K Owens', 18)}}的其他基金

Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
  • 批准号:
    10652788
  • 财政年份:
    2023
  • 资助金额:
    $ 37.88万
  • 项目类别:
Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis
平滑肌细胞胰岛素抵抗和全身代谢功能障碍在动脉粥样硬化发展和晚期病变发病机制中的作用
  • 批准号:
    10731723
  • 财政年份:
    2023
  • 资助金额:
    $ 37.88万
  • 项目类别:
Endothelial Cell to Mesenchymal Cell Transitions Play a Critical Biological Sex- and Aging-Dependent Role in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
内皮细胞向间充质细胞的转变在 Acta2 动脉粥样硬化病变保护性纤维帽的形成和维持中发挥着关键的生物性别和衰老依赖性作用
  • 批准号:
    10355596
  • 财政年份:
    2022
  • 资助金额:
    $ 37.88万
  • 项目类别:
Endothelial Cell to Mesenchymal Cell Transitions Play a Critical Biological Sex- and Aging-Dependent Role in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
内皮细胞向间充质细胞的转变在 Acta2 动脉粥样硬化病变保护性纤维帽的形成和维持中发挥着关键的生物性别和衰老依赖性作用
  • 批准号:
    10542427
  • 财政年份:
    2022
  • 资助金额:
    $ 37.88万
  • 项目类别:
Role of Metabolic Reprogramming in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
代谢重编程在 Acta2 动脉粥样硬化病变保护性纤维帽形成和维持中的作用
  • 批准号:
    10441555
  • 财政年份:
    2021
  • 资助金额:
    $ 37.88万
  • 项目类别:
Role of Metabolic Reprogramming in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
代谢重编程在 Acta2 动脉粥样硬化病变保护性纤维帽形成和维持中的作用
  • 批准号:
    10612042
  • 财政年份:
    2021
  • 资助金额:
    $ 37.88万
  • 项目类别:
Role of Metabolic Reprogramming in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
代谢重编程在 Acta2 动脉粥样硬化病变保护性纤维帽形成和维持中的作用
  • 批准号:
    10292012
  • 财政年份:
    2021
  • 资助金额:
    $ 37.88万
  • 项目类别:
IL1beta signaling in SMCpromotes beneficial changes in late stage atherosclerotic lesion pathogenesis
SMC 中的 IL1β 信号传导促进晚期动脉粥样硬化病变发病机制的有益变化
  • 批准号:
    10331329
  • 财政年份:
    2019
  • 资助金额:
    $ 37.88万
  • 项目类别:
Defining SMC phenotypes critical in late stage atherosclerosis pathogenesis
定义在晚期动脉粥样硬化发病机制中至关重要的 SMC 表型
  • 批准号:
    10084307
  • 财政年份:
    2018
  • 资助金额:
    $ 37.88万
  • 项目类别:
Oct4 and Klf4 regulate microvascular SMC-pericyte plasticity, angiogenesis, and metabolic dysfunction
Oct4 和 Klf4 调节微血管 SMC-周细胞可塑性、血管生成和代谢功能障碍
  • 批准号:
    9919376
  • 财政年份:
    2017
  • 资助金额:
    $ 37.88万
  • 项目类别:

相似海外基金

A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
  • 批准号:
    22KJ2613
  • 财政年份:
    2023
  • 资助金额:
    $ 37.88万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
The structural basis of plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
  • 批准号:
    342887
  • 财政年份:
    2016
  • 资助金额:
    $ 37.88万
  • 项目类别:
    Operating Grants
The structural basis for plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
  • 批准号:
    278338
  • 财政年份:
    2013
  • 资助金额:
    $ 37.88万
  • 项目类别:
    Operating Grants
Cytoplasmic Actins in Maintenance of Muscle Mitochondria
细胞质肌动蛋白在维持肌肉线粒体中的作用
  • 批准号:
    8505938
  • 财政年份:
    2012
  • 资助金额:
    $ 37.88万
  • 项目类别:
Differential Expression of the Diverse Plant Actins
多种植物肌动蛋白的差异表达
  • 批准号:
    7931495
  • 财政年份:
    2009
  • 资助金额:
    $ 37.88万
  • 项目类别:
Studies on how actins and microtubules are coordinated and its relevancy.
研究肌动蛋白和微管如何协调及其相关性。
  • 批准号:
    19390048
  • 财政年份:
    2007
  • 资助金额:
    $ 37.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Suppression of Arabidopsis Reproductive Actins
拟南芥生殖肌动蛋白的抑制
  • 批准号:
    6655612
  • 财政年份:
    2003
  • 资助金额:
    $ 37.88万
  • 项目类别:
Suppression of Arabidopsis Reproductive Actins
拟南芥生殖肌动蛋白的抑制
  • 批准号:
    6546977
  • 财政年份:
    2003
  • 资助金额:
    $ 37.88万
  • 项目类别:
Interaction of myosin with monomeric actins
肌球蛋白与单体肌动蛋白的相互作用
  • 批准号:
    5311554
  • 财政年份:
    2001
  • 资助金额:
    $ 37.88万
  • 项目类别:
    Priority Programmes
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
  • 批准号:
    6316669
  • 财政年份:
    2000
  • 资助金额:
    $ 37.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了